TXU (Anti-CD7)-Pokeweed Antiviral Protein as a Potent Inhibitor of Human Immunodeficiency Virus

We have evaluated the clinical potential of TXU (anti-CD7)-pokeweed antiviral protein (PAP) immunoconjugate (TXU-PAP) as a new biotherapeutic anti-human immunodeficiency virus (anti-HIV) agent by evaluating its anti-HIV type 1 (anti-HIV-1) activity in vitro, as well as in a surrogate human periphera...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Uckun, Fatih M., Chelstrom, Lisa M., Tuel-Ahlgren, Lisa, Dibirdik, Ilker, Irvin, James D., Langlie, Mridula-Chandan, Myers, Dorothea E.
Format: Artigo
Langue:Inglês
Publié: American Society for Microbiology 1998
Sujets:
Antiviral Agents
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC105418/
https://ncbi.nlm.nih.gov/pubmed/9527790
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires